Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: ASE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

CSL:AU

93.5500 AUD 1.5500 1.68%

As of 00:10:08 ET on 03/06/2015.

Snapshot for CSL Ltd (CSL)

Open: 92.4200 Day's Range: 92.2000 - 93.6600 Volume: 863,271
Previous Close: 92.0000 52wk Range: 63.7700 - 93.6600 1-Yr Rtn: +32.50%

Stock Chart for CSL

No chart data available.
  • CSL:AU 93.5500
  • 1D
  • 1M
  • 1Y
92.0000
Interactive CSL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CSL

Current P/E Ratio (ttm) 25.7692
Estimated P/E(06/2015) 24.2982
Relative P/E vs. AS51 1.2466
Earnings Per Share (USD) (ttm) 2.8312
Est. EPS (USD) (06/2015) 2.9860
Est. PEG Ratio 1.7497
Market Cap (M AUD) 44,290.26
Shares Outstanding (M) 473.90
30 Day Average Volume 1,882,119
Price/Book (mrq) 11.5239
Price/Sale (ttm) 6.3344
Dividend Indicated Gross Yield 1.49%
Cash Dividend (AUD) 0.7439
Dividend Ex-Date 03/16/2015
5 Year Dividend Growth 12.07%
Next Earnings Announcement 08/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CSL

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CSL

CSL Limited develops, manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines, infection and pain medicine, skin disorder remedies, antivenoms, anticoagulants and immunoglobulins.

John ShineChairmanPaul PerreaultCEO/Managing Director
Gordon NaylorChief Financial OfficerMary SontropExec VP:Manufacturing
More Company Profile & Key Executives for CSL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil